Terray Therapeutics
Healthcare AI
AI drug discovery / small-molecule therapeutics
Series B
Terray Therapeutics is a privately held biotechnology company focused on AI-enabled small-molecule drug discovery, combining ultra-high-throughput experimentation, proprietary hardware, large chemistry datasets, and generative AI to improve the speed, cost, and success rate of therapeutic development. It is based in the Los Angeles/Pasadena/Monrovia area of California and positions its platform for internal and partnered programs across multiple disease areas, including immunology and autoimmune disorders.
Company Details
- Website
- terraytx.ai
- Headquarters
- Monrovia, California, United States
- Founded
- 2018
- Funding
- $200M+
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring